Could surgery after meds tame tough prostate cancer?

NCT ID NCT07268794

First seen Jan 07, 2026 · Last updated May 05, 2026 · Updated 23 times

Summary

This study tests whether men with advanced prostate cancer that has spread to other parts of the body can benefit from having their prostate removed after initial drug therapy. Participants first receive 6 months of hormone-blocking drugs. Those whose scans show the cancer has quieted down are randomly assigned to either continue drugs alone or also have prostate surgery or radiation. The goal is to see if adding local treatment delays cancer growth and improves survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fudan University Shanghai Cancer Center

    Shanghai, 200032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.